Scholar IQ
Help
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsResearchersKey papersJournalsOpen accessInstitutions
ScholarIQanswers from OpenAlex

Head and Neck Cancer Studies

TopicLeading institutions, researchers & key papers

This cluster of papers focuses on the epidemiology, treatment, and prognosis of head and neck cancer, with a particular emphasis on human papillomavirus (HPV)-related oropharyngeal cancer. It covers topics such as the impact of HPV infection, the role of radiotherapy and chemotherapy, survival outcomes, and the molecular landscape of head and neck squamous cell carcinomas.

123,587
Works
1,659,471
Citations
How has Head and Neck Cancer Studies's publication output changed over time?
ScholarIQpublication output · 2016–2019

Output grew100% over the shown period — from 1 works in 2016 to 2 in 2019.

1
2
20162019
Who are the most-cited researchers behind Head and Neck Cancer Studies?
ScholarIQtop researchers by citations
1
Everett E. Vokes · Head and Neck Cancer Studies
1,234 works80,130 citations
2
Michael Boyer · Lung Cancer Treatments and Mutations
612 works51,567 citations
3
George R. Blumenschein · Lung Cancer Treatments and Mutations
725 works42,637 citations
4
Tibor Csőszi · Advanced Breast Cancer Therapies
254 works34,062 citations
5
Gilberto de Castro · Cancer Immunotherapy and Biomarkers
462 works31,572 citations
What are the most-cited papers on Head and Neck Cancer Studies?
ScholarIQmost cited works
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
Robert L. Ferris, George R. Blumenschein, Jérôme Fayette, J. Guigay, A. Dimitrios Colevas, Lisa Licitra, Kevin J. Harrington, Stefan Kasper, Everett E. Vokes, Caroline Even, Francis P. Worden, Nabil F. Saba, Lara Carmen Iglesias Docampo, Robert I. Haddad, Tamara Rordorf, Naomi Kiyota, Makoto Tahara, Manish Monga, Mark Lynch, William J. Geese, Justin Kopit, James W. Shaw, Maura L. Gillison
New England Journal of Medicine. 20165,107 CitationsOPEN ACCESS
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
Barbara Burtness, Kevin J. Harrington, Richard Greil, Denis Soulières, Makoto Tahara, Gilberto de Castro, Amanda Psyrri, Neus Basté, Prakash Neupane, Åse Bratland, Thorsten Fuereder, Brett Hughes, Ricard Mesı́a, Nuttapong Ngamphaiboon, Tamara Rordorf, Wan Zamaniah Wan Ishak, Ruey‐Long Hong, René González Mendoza, Ananya Roy, Yayan Zhang, Burak Gümüşçü, Jonathan D. Cheng, Fan Jin, Danny Rischin, Guillermo Lerzo, Marcelo Tatangelo, Mirta Varela, Juan José Zarbá, Michael Boyer, Hui Gan, Bo Gao, Brett Hughes, Girish Mallesara, Danny Rischin, Anne L. Taylor, Martin Burian, Thorsten Fuereder, Richard Greil, Carlos H. Barrios, Dalvaro Oliveira de Castro Junior, Gilberto de Castro, Fábio Franke, Gustavo Girotto, Iane Pinto Figueiredo Lima, Ulisses Ribaldo Nicolau, Gustavo Dix Junqueira Pinto, Lucas Vieira dos Santos, Ana-Paula Victorino, Neil Chua, Félix Couture, Richard Gregg, Aaron R. Hansen, John Hilton, Joy McCarthy, Denis Soulières, Rodrigo Ascuí, Pablo Gonzalez, Luis J. Villanueva-Rivera, Marco Torregroza, Ángela R. Zambrano, Petra Holečková, Zdeněk Král, Bohuslav Melichar, Prausova Jana, Milan Vošmik, Maria Andersen, Niels Gyldenkerne, Hannes Jürgens, Kadri Putnik, Petri Reinikainen, Viktor Gruenwald, Simon Laban, Gerasimos Aravantinos, Ioannis Boukovinas, Vassilis Georgoulias, Amanda Psyrri, D.L.W. Kwong, Yousuf Al-Farhat, Tibor Csőszi, József Erfán, Geza Horvai, László Landherr, Éva Remenár, Ágnes Ruzsa, Judit Szota, Salem Billan, Iris Gluck, Orit Gutfeld, Aron Popovtzer, Marco Benasso, Simona Bui, Vittorio Ferrari, Lisa Licitra, Franco Nolè, Takashi Fujii, Yasushi Fujimoto, Nobuhiro Hanai, Hiroki Hara, Koji Matsumoto, Kenji Mitsugi
The Lancet. 20193,244 CitationsOPEN ACCESS
Nasopharyngeal carcinoma
Yu‐Pei Chen, Anthony T.�C. Chan, Quynh‐Thu Le, Pierre Blanchard, Ying Sun, Jun Ma
The Lancet. 20193,097 Citations
Where is Head and Neck Cancer Studies research published, and who funds it?
ScholarIQvenues & funding sources
TOP FUNDERS
National Science Foundation
NIH
Wellcome Trust
European Research Council
Funder breakdown is a member featureSign up free to unlock
How much of the research on Head and Neck Cancer Studies is open access?
ScholarIQopen access share
67%OPEN ACCESS
Gold
0%
Green
0%
Hybrid
0%
Bronze
67%
Closed
33%
Who collaborates most closely around Head and Neck Cancer Studies?
ScholarIQco-authorship network
United States
58%
France
25%
Switzerland
8%
Germany
8%
Related on ScholarIQ
The University of Texas MD Anderson Cancer Center
Institution
Institut Gustave Roussy
Institution
University Hospital of Zurich
Institution
The Ohio State University
Institution
Stanford University
Institution
Dana-Farber Cancer Institute
Institution
470M+ articles · free account